Sparo, founded in St. Louis, Missouri, is a digital health company dedicated to transforming respiratory care from reactive to proactive. The company's core mission is to empower individuals with tools for better lung health management. Sparo's flagship product, Wing™, is the first FDA-cleared, over-the-counter smartphone sensor designed to measure lung function, providing users with a convenient and accessible way to monitor their respiratory health. The company primarily focuses on the respiratory care market, aiming to improve outcomes for individuals with chronic lung conditions.

Notable figures associated with Sparo include its founders and key investors who have supported its innovative approach to respiratory health. The company has achieved significant milestones, including obtaining FDA clearance for Wing™, which underscores its commitment to regulatory compliance and product efficacy. Sparo's impact is evident in its contribution to making advanced respiratory monitoring accessible to a broader audience, potentially improving the quality of life for many individuals with respiratory issues.